New Trends in the Detection of Gynecological Precancerous
Lesions and Early-Stage Cancers

J 2021

New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers

HOLCAKOVA, Jitka, Martin BARTOSIK, Milan ANTON, Luboš MINÁŘ, Jitka HAUSNEROVÁ et. al.

Basic information

Original name

New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers

Authors

HOLCAKOVA, Jitka (203 Czech Republic), Martin BARTOSIK (203 Czech Republic), Milan ANTON (203 Czech Republic, belonging to the institution), Luboš MINÁŘ (203 Czech Republic, belonging to the institution), Jitka HAUSNEROVÁ (203 Czech Republic, belonging to the institution), Markéta BEDNAŘÍKOVÁ (203 Czech Republic, belonging to the institution), Vít WEINBERGER (203 Czech Republic, belonging to the institution) and Roman HRSTKA (203 Czech Republic)

Edition

Cancers, BASEL, MDPI, 2021, 2072-6694

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 6.575

RIV identification code

RIV/00216224:14110/21:00123642

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.3390/cancers13246339

UT WoS

000736133100001

Keywords in English

cervical cancer; endometrial cancer; ovarian cancer; precancer; liquid biopsy

Abstract

V originále

Simple Summary This review deals with the prospects of early diagnostics in cervical, endometrial, and ovarian cancers. Progress in cancer research has enabled the rapid development of cancer diagnostics, treatments, and preventions. Indeed, the current situation in genital tract tumors reflects the trend in contemporary oncology that emphasizes cancer prevention and early diagnostics. Cervical cancer screening using cytological examination has a long tradition, is highly effective, and is now being complemented with HPV triage, allowing early diagnostics even in precancerous stages due to the relative ease of accessibility of the uterine cervix. Moreover, vaccination against HPV, which is major cause of cervical cancer, is now recommended for both girls and boys at an early age. In contrast, endometrial and, particularly, ovarian cancers are poorly accessible by sampling, and neither prevention nor screening methods readily exist. Thus, other options leading to their early diagnostics are discussed, in which circulating biomarkers play key roles. The prevention and early diagnostics of precancerous stages are key aspects of contemporary oncology. In cervical cancer, well-organized screening and vaccination programs, especially in developed countries, are responsible for the dramatic decline of invasive cancer incidence and mortality. Cytological screening has a long and successful history, and the ongoing implementation of HPV triage with increased sensitivity can further decrease mortality. On the other hand, endometrial and ovarian cancers are characterized by a poor accessibility to specimen collection, which represents a major complication for early diagnostics. Therefore, despite relatively promising data from evaluating the combined effects of genetic variants, population screening does not exist, and the implementation of new biomarkers is, thus, necessary. The introduction of various circulating biomarkers is of potential interest due to the considerable heterogeneity of cancer, as highlighted in this review, which focuses exclusively on the most common tumors of the genital tract, namely, cervical, endometrial, and ovarian cancers. However, it is clearly shown that these malignancies represent different entities that evolve in different ways, and it is therefore necessary to use different methods for their diagnosis and treatment.

Links

90125, large research infrastructures

Name: BBMRI-CZ III

90128, large research infrastructures

Name: CZECRIN III

Citovat

HOLCAKOVA, Jitka, Martin BARTOSIK, Milan ANTON, Luboš MINÁŘ, Jitka HAUSNEROVÁ, Markéta BEDNAŘÍKOVÁ, Vít WEINBERGER and Roman HRSTKA. New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers. Cancers. BASEL: MDPI, 2021, vol. 13, No 24, p. 1-23. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers13246339.

@article{1819484,
   author = {Holcakova, Jitka and Bartosik, Martin and Anton, Milan and Minář, Luboš and Hausnerová, Jitka and Bednaříková, Markéta and Weinberger, Vít and Hrstka, Roman},
   article_location = {BASEL},
   article_number = {24},
   doi = {http://dx.doi.org/10.3390/cancers13246339},
   keywords = {cervical cancer; endometrial cancer; ovarian cancer; precancer; liquid biopsy},
   language = {eng},
   issn = {2072-6694},
   journal = {Cancers},
   title = {New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers},
   url = {https://www.mdpi.com/2072-6694/13/24/6339},
   volume = {13},
   year = {2021}
}

TY  - JOUR
ID  - 1819484
AU  - Holcakova, Jitka - Bartosik, Martin - Anton, Milan - Minář, Luboš - Hausnerová, Jitka - Bednaříková, Markéta - Weinberger, Vít - Hrstka, Roman
PY  - 2021
TI  - New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers
JF  - Cancers
VL  - 13
IS  - 24
SP  - 1-23
EP  - 1-23
PB  - MDPI
SN  - 20726694
KW  - cervical cancer
KW  - endometrial cancer
KW  - ovarian cancer
KW  - precancer
KW  - liquid biopsy
UR  - https://www.mdpi.com/2072-6694/13/24/6339
N2  - Simple Summary This review deals with the prospects of early diagnostics in cervical, endometrial, and ovarian cancers. Progress in cancer research has enabled the rapid development of cancer diagnostics, treatments, and preventions. Indeed, the current situation in genital tract tumors reflects the trend in contemporary oncology that emphasizes cancer prevention and early diagnostics. Cervical cancer screening using cytological examination has a long tradition, is highly effective, and is now being complemented with HPV triage, allowing early diagnostics even in precancerous stages due to the relative ease of accessibility of the uterine cervix. Moreover, vaccination against HPV, which is major cause of cervical cancer, is now recommended for both girls and boys at an early age. In contrast, endometrial and, particularly, ovarian cancers are poorly accessible by sampling, and neither prevention nor screening methods readily exist. Thus, other options leading to their early diagnostics are discussed, in which circulating biomarkers play key roles. The prevention and early diagnostics of precancerous stages are key aspects of contemporary oncology. In cervical cancer, well-organized screening and vaccination programs, especially in developed countries, are responsible for the dramatic decline of invasive cancer incidence and mortality. Cytological screening has a long and successful history, and the ongoing implementation of HPV triage with increased sensitivity can further decrease mortality. On the other hand, endometrial and ovarian cancers are characterized by a poor accessibility to specimen collection, which represents a major complication for early diagnostics. Therefore, despite relatively promising data from evaluating the combined effects of genetic variants, population screening does not exist, and the implementation of new biomarkers is, thus, necessary. The introduction of various circulating biomarkers is of potential interest due to the considerable heterogeneity of cancer, as highlighted in this review, which focuses exclusively on the most common tumors of the genital tract, namely, cervical, endometrial, and ovarian cancers. However, it is clearly shown that these malignancies represent different entities that evolve in different ways, and it is therefore necessary to use different methods for their diagnosis and treatment.
ER  -

HOLCAKOVA, Jitka, Martin BARTOSIK, Milan ANTON, Luboš MINÁŘ, Jitka HAUSNEROVÁ, Markéta BEDNAŘÍKOVÁ, Vít WEINBERGER and Roman HRSTKA. New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers. \textit{Cancers}. BASEL: MDPI, 2021, vol.~13, No~24, p.~1-23. ISSN~2072-6694. Available from: https://dx.doi.org/10.3390/cancers13246339.

Detailed Information on Publication Record